Profile | GDS4284 / 222892_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 48.7145 | 24 |
GSM687648 | Patient 402 control | 152.433 | 44 |
GSM687653 | Patient 403 control | 121.914 | 40 |
GSM687658 | Patient 404 control | 330.349 | 57 |
GSM687663 | Patient 411 control | 205.988 | 48 |
GSM687668 | Patient 422 control | 16.3164 | 10 |
GSM687673 | Patient 424 control | 212.971 | 48 |
GSM687678 | Patient 425 control | 240.293 | 50 |
GSM687683 | Patient 427 control | 232.731 | 49 |
GSM687688 | Patient 428 control | 26.735 | 16 |
GSM687695 | Patient 441 control | 2529.08 | 88 |
GSM687699 | Patient 443 control | 18.2958 | 9 |
GSM687704 | Patient 444 control | 193.623 | 48 |
GSM687707 | Patient 448 control | 226.915 | 47 |
GSM687712 | Patient 449 control | 199.352 | 48 |
GSM687719 | Patient 450 control | 364.449 | 57 |
GSM687724 | Patient 451 control | 386.734 | 59 |
GSM687728 | Patient 452 control | 455.64 | 62 |
GSM687646 | Patient 401 treated 24h | 50.9372 | 23 |
GSM687649 | Patient 402 treated 24h | 288.388 | 56 |
GSM687665 | Patient 411 treated 24h | 130.042 | 37 |
GSM687651 | Patient 402 treated 4 weeks | 249.489 | 51 |
GSM687667 | Patient 411 treated 4 weeks | 172.547 | 45 |
GSM687670 | Patient 422 treated 24h | 55.3793 | 24 |
GSM687671 | Patient 422 treated 4 weeks | 192.622 | 48 |
GSM687654 | Patient 403 treated 24h | 36.3176 | 21 |
GSM687675 | Patient 424 treated 24h | 140.931 | 39 |
GSM687685 | Patient 427 treated 24h | 80.8936 | 30 |
GSM687656 | Patient 403 treated 4 weeks | 236.319 | 53 |
GSM687677 | Patient 424 treated 4 weeks | 132.843 | 40 |
GSM687687 | Patient 427 treated 4 weeks | 35.0082 | 20 |
GSM687692 | Patient 428 treated 4h | 106.284 | 35 |
GSM687716 | Patient 449 treated 4h | 160.146 | 45 |
GSM687722 | Patient 450 treated 4h | 260.065 | 51 |
GSM687680 | Patient 425 treated 24h | 176.181 | 46 |
GSM687690 | Patient 428 treated 24h | 164.584 | 45 |
GSM687700 | Patient 443 treated 24h | 724.087 | 68 |
GSM687705 | Patient 444 treated 24h | 209.312 | 51 |
GSM687714 | Patient 449 treated 24h | 155.531 | 45 |
GSM687721 | Patient 450 treated 24h | 248.401 | 49 |
GSM687682 | Patient 425 treated 4 weeks | 35.7017 | 19 |
GSM687694 | Patient 428 treated 4 weeks | 124.607 | 41 |
GSM687702 | Patient 443 treated 4 weeks | 267.811 | 51 |
GSM687718 | Patient 449 treated 4 weeks | 32.5122 | 17 |
GSM687723 | Patient 450 treated 4 weeks | 80.5753 | 29 |
GSM687661 | Patient 404 treated 4h | 166.263 | 43 |
GSM687710 | Patient 448 treated 4h | 427.387 | 62 |
GSM687726 | Patient 451 treated 4h | 355.482 | 57 |
GSM687730 | Patient 452 treated 4h | 1399.62 | 80 |
GSM687660 | Patient 404 treated 24h | 1772.59 | 84 |
GSM687697 | Patient 441 treated 24h | 1293.62 | 78 |
GSM687709 | Patient 448 treated 24h | 136.576 | 38 |
GSM687725 | Patient 451 treated 24h | 437.494 | 60 |
GSM687729 | Patient 452 treated 24h | 1841.69 | 84 |
GSM687727 | Patient 451 treated 4 weeks | 406.005 | 59 |
GSM687731 | Patient 452 treated 4 weeks | 694.068 | 68 |